Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Nov:214:12-19.e3.
doi: 10.1016/j.jpeds.2019.06.061. Epub 2019 Jul 31.

Measuring the Severity of Respiratory Illness in the First 2 Years of Life in Preterm and Term Infants

Mary T Caserta  1 , Hongmei Yang  2 , Sanjukta Bandyopadhyay  2 , Xing Qiu  2 , Steven R Gill  3 , James Java  3 , Andrew McDavid  2 , Ann R Falsey  4 , David J Topham  5 , Jeanne Holden-Wiltse  6 , Kristin Scheible  7 , Gloria Pryhuber  8
Affiliations
Clinical Trial

Measuring the Severity of Respiratory Illness in the First 2 Years of Life in Preterm and Term Infants

Mary T Caserta et al. J Pediatr. 2019 Nov.

Abstract

Objective: To develop a valid research tool to measure infant respiratory illness severity using parent-reported symptoms.

Study design: Nose and throat swabs were collected monthly for 1 year and during respiratory illnesses for 2 years in a prospective study of term and preterm infants in the Prematurity, Respiratory Outcomes, Immune System and Microbiome study. Viral pathogens were detected using Taqman Array Cards. Parents recorded symptoms during respiratory illnesses using a Childhood Origins of Asthma (COAST) scorecard. The COAST score was validated using linear mixed effects regression modeling to evaluate associations with hospitalization and specific infections. A data-driven method was also used to compute symptom weights and derive a new score, the Infant Research Respiratory Infection Severity Score (IRRISS). Linear mixed effects regression modeling was repeated with the IRRISS illness data.

Results: From April 2013 to April 2017, 50 term, 40 late preterm, and 28 extremely low gestational age (<29 weeks of gestation) infants had 303 respiratory illness visits with viral testing and parent-reported symptoms. A range of illness severity was described with 39% of illness scores suggestive of severe disease. Both the COAST score and IRRISS were associated with respiratory syncytial virus infection and hospitalization. Gestational age and human rhinovirus infection were inversely associated with both scoring systems. The IRRISS and COAST scores were highly correlated (r = 0.93; P < .0001).

Conclusions: Using parent-reported symptoms, we validated the COAST score as a measure of respiratory illness severity in infants. The new IRRISS score performed as well as the COAST score.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency distribution of the parent-reported maximal COAST score for respiratory illness visits by cohort.
Figure 2
Figure 2
Cluster dendrogram of respiratory symptoms. The dendrogram was created with data from the dissimilarity matrix analyses of respiratory symptoms including wheeze, cough, hoarseness, tachypnea, retractions, sick for >4 days, runny nose and fever. It suggests a physiologic relationship among these 8 symptoms.
Figure 3
Figure 3
Computation of the IRRSS score. Respiratory symptom weights were computed via factor analysis with polychoric correlation matrix of symptoms. The final IRRSS was computed as: IRRSS = 0.07 × Severe runny nose today − 0.25 × Mild runny nose today + 0.08 × Fever >100°F today − 0.17 × Sick >4 days + 0.87 × Breathing fast today + 0.82 × Retractions today + 0.91 + Wheeze Today + 0.34 × Hoarse today + 0.71 × Severe cough today − 0.08 × Moderate cough today − 0.37 × Mild cough today + 10.
Figure 4
Figure 4
Correlation between the maximal COAST score and the maximal IRRSS. The scores were significantly correlated (r = 0.93; P < .0001).
See this image and copyright information in PMC

References

    1. Monto A.S., Malosh R.E., Petrie J.G., Thompson M.G., Ohmit S.E. Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons. J Infect Dis. 2014;210:1792–1799. - PMC - PubMed
    1. Yorita K.L., Holman R.C., Sejvar J.J., Steiner C.A., Schonberger L.B. Infectious disease hospitalizations among infants in the United States. Pediatrics. 2008;121:244–252. - PubMed
    1. Blanken M.O., Rovers M.M., Molenaar J.M., Winkler-Seinstra P.L., Meijer A., Kimpen J.L. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368:1791–1799. - PubMed
    1. Stein R.T., Martinez F.D. Respiratory syncytial virus and asthma: still no final answer. Thorax. 2010;65:1033–1034. - PubMed
    1. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541–545. - PubMed

Publication types